Franklin Resources’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Franklin Resources’s Portfolio CNCE Stock Details CNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-30,000	Closed	-$201K	–	2405
2022 Q3	$201K	Sell	30,000 -40,000	-57%	-$242K	﹤0.01%	1995
2022 Q2	$295K	Buy	+70,000	New	+$277K	﹤0.01%	1876
2019 Q1	–	Sell	-556,600	Closed	-$6.99M	–	1545
2018 Q4	$6.99M	Sell	556,600 -162	-0%	-$2.24K	﹤0.01%	939
2018 Q3	$8.26M	Sell	556,762 -20,273	-4%	-$319K	﹤0.01%	962
2018 Q2	$9.71M	Buy	577,035 +135	+0%	+$2.62K	0.01%	925
2018 Q1	$13.2M	Sell	576,900 -25,700	-4%	-$572K	0.01%	875
2017 Q4	$15.6M	Sell	602,600 -84,400	-12%	-$1.7M	0.01%	852
2017 Q3	$10.1M	Hold	687,000	–	–	0.01%	940
2017 Q2	$9.58M	Hold	687,000	–	–	﹤0.01%	955
2017 Q1	$11.7M	Hold	687,000	–	–	0.01%	926
2016 Q4	$7.07M	Hold	687,000	–	–	﹤0.01%	1030
2016 Q3	$6.95M	Hold	687,000	–	–	﹤0.01%	1051
2016 Q2	$7.71M	Hold	687,000	–	–	﹤0.01%	1013
2016 Q1	$9.38M	Hold	687,000	–	–	0.01%	997
2015 Q4	$13M	Hold	687,000	–	–	0.01%	947
2015 Q3	$12.9M	Hold	687,000	–	–	0.01%	953
2015 Q2	$10.2M	Hold	687,000	–	–	﹤0.01%	1034
2015 Q1	$10.4M	Hold	687,000	–	–	﹤0.01%	1044
2014 Q4	$9.15M	Hold	687,000	–	–	﹤0.01%	1066
2014 Q3	$8.66M	Hold	687,000	–	–	﹤0.01%	1069
2014 Q2	$6.94M	Hold	687,000	–	–	﹤0.01%	1123
2014 Q1	$9.24M	Buy	+687,000	New	+$9.7M	﹤0.01%	1053

Other funds holding CNCE

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources's CNCE Position: Q4 2022 in Review

Franklin Resources sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q4 2022, closing a stake of 30,000 shares — an estimated $201K sold.

Franklin Resources first reported a position in CNCE in Q1 2014 and held it in 22 quarters. The position peaked at $15.6M in Q4 2017. 84 funds tracked by Wall St. Rank hold CNCE as of Q4 2022.

Franklin Resources reported no remaining Concert Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
Franklin Resources sold 30,000 Concert Pharmaceuticals, Inc. shares in Q4 2022, an estimated $201K.
Franklin Resources first reported a position in Concert Pharmaceuticals, Inc. in Q1 2014 and held it in 22 quarters.
Franklin Resources's Concert Pharmaceuticals, Inc. position peaked at $15.6M in Q4 2017.
84 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q4 2022.

Based on Franklin Resources's 13F filing for Q4 2022, filed 10 Feb 2023.